Genedx Holdings Corp. · NASDAQ:WGS
Stueland Katherine sold 10,501 Genedx Holdings Corp. shares (Form 4)
Traded Jun 16, 2026 · Filed Jun 18, 2026
On Jun 16, 2026, Stueland Katherine (Director, CHIEF EXECUTIVE OFFICER) sold 10,501 Genedx Holdings Corp. shares at an average US$60.76 for US$638K, leaving 104,372 shares. Filed Jun 18, 2026 (Form 4).
- Sold
- 10,501 shares
- Price
- US$60.76 average (US$59.75 to US$61.50)
- Value
- US$638K
- Holding after
- 104,372 shares
- Trading plan
- No
- Role
- Director, CHIEF EXECUTIVE OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 16, 2026 | Class A Common Stock | Option exercise | 18,750 | 114,873 | Direct | |
| Jun 16, 2026 | Class A Common Stock | Sale | 2,140 | US$59.75 | 112,733 | Direct |
| Jun 16, 2026 | Class A Common Stock | Sale | 5,932 | US$60.83 | 106,801 | Direct |
| Jun 16, 2026 | Class A Common Stock | Sale | 2,429 | US$61.50 | 104,372 | Direct |
Source
Related
- Genedx Holdings Corp.
- Stueland Katherine
- Genedx Holdings Corp. shareholders
- Form 4 · Stueland Katherine · Sep 18, 2026
- Form 4 · Stueland Katherine · Sep 11, 2026
- Form 4 · Stueland Katherine · Jun 11, 2026
- Form 4 · Stueland Katherine · May 1, 2026
- Form 4 · Fuchs Thomas · Sep 18, 2026
- Form 4 · Feeley Kevin · Sep 18, 2026
- Form 4 · Feeley Kevin · Sep 11, 2026
- Form 4 · Feeley Kevin · Sep 3, 2026
- Schedule 13G · Goldman Sachs Group Inc · Aug 11, 2026